CZ2016539A3 - Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy - Google Patents
Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy Download PDFInfo
- Publication number
- CZ2016539A3 CZ2016539A3 CZ2016-539A CZ2016539A CZ2016539A3 CZ 2016539 A3 CZ2016539 A3 CZ 2016539A3 CZ 2016539 A CZ2016539 A CZ 2016539A CZ 2016539 A3 CZ2016539 A3 CZ 2016539A3
- Authority
- CZ
- Czechia
- Prior art keywords
- ezetimibe
- layer
- rosuvastatin
- pharmaceutically acceptable
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2016-539A CZ2016539A3 (cs) | 2016-09-05 | 2016-09-05 | Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy |
| MA046100A MA46100A (fr) | 2016-09-05 | 2017-08-31 | Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation |
| IL265172A IL265172B (en) | 2016-09-05 | 2017-08-31 | A pharmaceutical composition containing rovastatin and ezetimibe and a method for making it |
| EA201990652A EA201990652A1 (ru) | 2016-09-05 | 2017-08-31 | Фармацевтическая композиция, содержащая два различных активных ингредиента, и способ ее получения |
| MX2019002516A MX2019002516A (es) | 2016-09-05 | 2017-08-31 | Una composicion farmaceutica que comprende rosuvastatina y ezetimibe y un metodo de preparacion de la misma. |
| JP2019512660A JP7094944B2 (ja) | 2016-09-05 | 2017-08-31 | ロスバスタチン及びエゼチミブを含む医薬組成物並びにその調製方法 |
| EP17771980.4A EP3506888A1 (en) | 2016-09-05 | 2017-08-31 | A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof |
| KR1020197009428A KR102517765B1 (ko) | 2016-09-05 | 2017-08-31 | 로수바스타틴 및 에제티미브를 포함하는 제약 조성물 및 그의 제조 방법 |
| TW106129702A TWI811195B (zh) | 2016-09-05 | 2017-08-31 | 包含兩種不同活性原料的醫藥組成物及其製備方法 |
| CN201780067887.8A CN110418637A (zh) | 2016-09-05 | 2017-08-31 | 包含瑞舒伐他汀和依泽替米贝的药物组合物及其制备方法 |
| PCT/CZ2017/050037 WO2018041282A1 (en) | 2016-09-05 | 2017-08-31 | A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof |
| US16/330,268 US11786526B2 (en) | 2016-09-05 | 2017-08-31 | Pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof |
| BR112019004269A BR112019004269A2 (pt) | 2016-09-05 | 2017-08-31 | composição farmacêutica compreendendo rosuvastatina e ezetimiba e método para sua preparação |
| ZA2019/01342A ZA201901342B (en) | 2016-09-05 | 2019-03-04 | A pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2016-539A CZ2016539A3 (cs) | 2016-09-05 | 2016-09-05 | Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ2016539A3 true CZ2016539A3 (cs) | 2018-03-14 |
Family
ID=59955311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ2016-539A CZ2016539A3 (cs) | 2016-09-05 | 2016-09-05 | Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11786526B2 (pt) |
| EP (1) | EP3506888A1 (pt) |
| JP (1) | JP7094944B2 (pt) |
| KR (1) | KR102517765B1 (pt) |
| CN (1) | CN110418637A (pt) |
| BR (1) | BR112019004269A2 (pt) |
| CZ (1) | CZ2016539A3 (pt) |
| EA (1) | EA201990652A1 (pt) |
| IL (1) | IL265172B (pt) |
| MA (1) | MA46100A (pt) |
| MX (1) | MX2019002516A (pt) |
| TW (1) | TWI811195B (pt) |
| WO (1) | WO2018041282A1 (pt) |
| ZA (1) | ZA201901342B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7115825B2 (ja) * | 2017-06-28 | 2022-08-09 | 日医工株式会社 | エゼチミブ含有経口製剤及びその製造方法 |
| JP2019014700A (ja) * | 2017-07-11 | 2019-01-31 | 大原薬品工業株式会社 | エゼチミブ含有口腔内崩壊錠及びその製造方法 |
| BR112022001783A2 (pt) | 2019-07-31 | 2022-03-22 | Tecnimede Soc Tecnico Medicinal Sa | Composições orais sólidas multiunitárias de liberação imediata, seus métodos e usos. |
| WO2022023206A1 (en) * | 2020-07-27 | 2022-02-03 | Krka, D.D., Novo Mesto | Bilayer tablet comprising ezetimibe and atorvastatin |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE390127T1 (de) * | 2003-09-01 | 2008-04-15 | Jpm The Jordanian Pharmaceutic | Universelle zusammensetzung zur kontrollierten wirkstoffabgabe enthaltend chitosan |
| WO2009024889A2 (en) | 2007-08-21 | 2009-02-26 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe |
| EP2168573A1 (en) | 2008-09-30 | 2010-03-31 | LEK Pharmaceuticals D.D. | Formulations comprising ezetimibe |
| EP2448919A2 (en) | 2009-07-02 | 2012-05-09 | Mahmut Bilgic | Solubility and stability enchancing pharmaceutical formulation |
| EP2459175B1 (en) * | 2009-07-28 | 2017-11-01 | Egis Gyógyszergyár Zrt. | New granulating process and thus prepared granulate |
| TR201009397A2 (tr) | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Rosuvastatin içeren farmasötik bileşimler. |
| WO2013066279A1 (en) | 2011-10-13 | 2013-05-10 | Mahmut Bilgic | Solid dosage forms comprising ezetimibe |
| EP2844233B1 (en) | 2012-05-01 | 2020-05-06 | Althera Life Sciences, LLC | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases |
| MX2012014970A (es) * | 2012-12-18 | 2013-08-27 | Hetlabs Mexico S A De C V | Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso. |
| HU231036B1 (hu) * | 2013-09-30 | 2019-12-30 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Koleszterin bioszintézis gátló hatóanyagot és koleszterin abszorpciót gátló hatóanyagot tartalmazó kombinációs gyógyszerkészítmény |
| CN103585157B (zh) * | 2013-11-13 | 2016-02-03 | 武汉武药科技有限公司 | 一种含依折麦布和瑞舒伐他汀的双层片及其制备方法 |
| KR20150079373A (ko) * | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| KR101977785B1 (ko) * | 2014-06-25 | 2019-05-14 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법 |
| FR3030251B1 (fr) * | 2014-12-22 | 2018-11-02 | L'oreal | Composition comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un solvant particulier |
| CN105310993A (zh) | 2015-11-17 | 2016-02-10 | 深圳信立泰药业股份有限公司 | 一种含有依折麦布的药物组合物及其制备方法 |
-
2016
- 2016-09-05 CZ CZ2016-539A patent/CZ2016539A3/cs unknown
-
2017
- 2017-08-31 IL IL265172A patent/IL265172B/en unknown
- 2017-08-31 TW TW106129702A patent/TWI811195B/zh active
- 2017-08-31 JP JP2019512660A patent/JP7094944B2/ja active Active
- 2017-08-31 CN CN201780067887.8A patent/CN110418637A/zh active Pending
- 2017-08-31 WO PCT/CZ2017/050037 patent/WO2018041282A1/en active Application Filing
- 2017-08-31 EP EP17771980.4A patent/EP3506888A1/en active Pending
- 2017-08-31 EA EA201990652A patent/EA201990652A1/ru unknown
- 2017-08-31 BR BR112019004269A patent/BR112019004269A2/pt active Search and Examination
- 2017-08-31 US US16/330,268 patent/US11786526B2/en active Active
- 2017-08-31 KR KR1020197009428A patent/KR102517765B1/ko active IP Right Grant
- 2017-08-31 MA MA046100A patent/MA46100A/fr unknown
- 2017-08-31 MX MX2019002516A patent/MX2019002516A/es unknown
-
2019
- 2019-03-04 ZA ZA2019/01342A patent/ZA201901342B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102517765B1 (ko) | 2023-04-03 |
| MA46100A (fr) | 2019-07-10 |
| IL265172B (en) | 2022-09-01 |
| ZA201901342B (en) | 2020-10-28 |
| JP7094944B2 (ja) | 2022-07-04 |
| TW201818938A (zh) | 2018-06-01 |
| KR20190045286A (ko) | 2019-05-02 |
| WO2018041282A1 (en) | 2018-03-08 |
| IL265172A (en) | 2019-05-30 |
| US20200009136A1 (en) | 2020-01-09 |
| TWI811195B (zh) | 2023-08-11 |
| BR112019004269A2 (pt) | 2019-06-04 |
| US11786526B2 (en) | 2023-10-17 |
| EA201990652A1 (ru) | 2019-08-30 |
| EP3506888A1 (en) | 2019-07-10 |
| CN110418637A (zh) | 2019-11-05 |
| JP2019526591A (ja) | 2019-09-19 |
| MX2019002516A (es) | 2019-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200163882A1 (en) | Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists | |
| NZ555901A (en) | Matrix type sustained-release preparation containing donepezil hydrochloride and / or memantine hydrochloride | |
| WO2008027600A2 (en) | Imatinib compositions | |
| US20130052262A1 (en) | Dabigatran etexilate-containing oral pharmaceutical composition | |
| US11786526B2 (en) | Pharmaceutical composition comprising rosuvastatin and ezetimibe and a preparation method thereof | |
| WO2018073839A1 (en) | Amorphous osimertinib mesylate, processes for its preparation and solid amorphous dispersions thereof | |
| US20200368185A1 (en) | Combination formulation containing sustained release metformin and immediate release hmg-coa reductase inhibitor | |
| US20120141586A1 (en) | Thrombin receptor antagonist and clopidogrel fixed dose tablet | |
| EP3658122A1 (en) | Pharmaceutical composition comprising sacubitril and valsartan | |
| WO2018211479A1 (en) | Stabilized compositions of angiotensin ii inhibitors and neutral endopeptidase inhibitors and process for preparation thereof | |
| CZ2016538A3 (cs) | Farmaceutická kompozice obsahující dvě rozdílné účinné látky | |
| WO2019142207A1 (en) | Pharmaceutical compositions comprising ibrutinib | |
| WO2011080706A1 (en) | Enhanced solubility of ziprasidone | |
| EP1909761B1 (en) | Pharmaceutical composition comprising granular pantoprazole | |
| US9750700B2 (en) | Imatinib mesylate oral pharmaceutical composition and process for preparation thereof | |
| EP3236952B1 (en) | Pharmaceutical tablet composition | |
| US11865215B2 (en) | Tablet compositions comprising abiraterone acetate | |
| EA040745B1 (ru) | Фармацевтическая композиция, содержащая два различных активных ингредиента, и способ ее получения | |
| WO2007029124A2 (en) | Formulations containing pantoprazole free acid and its salts | |
| US20130273158A1 (en) | Extended release compositions of quetiapine | |
| WO2023195022A1 (en) | Stable pharmaceutical compositions comprising erdafitinib | |
| EA042489B1 (ru) | Фармацевтическая композиция, включающая сакубитрил и валсартан | |
| US20190070167A1 (en) | Pitavastatin containing preparation and method for producing same |